High-flow nasal cannula therapy for hypoxemic respiratory failure in patients with COVID-19

INTRODUCTION: High-flow nasal cannula (HFNC) therapy in patients with hypoxemic respiratory failure due to COVID-19 is poorly understood and remains controversial. METHODS: We evaluated a large cohort of patients with COVID-19-related hypoxemic respiratory failure at the temporary COVID-19 hospital...

Descripción completa

Detalles Bibliográficos
Autores principales: Chavarria, Adrian Palacios, Lezama, Erika Salinas, Navarro, Mauricio Gonzalez, Vazquez, Rafael Ricardo Valdez, Bello, Héctor Herrera, Gascon, Julieta Lomelín, Juárez, Linda Morales, Avendaño, Mónica Arboleya, Gonzalez, Luis Esteban Ramirez, Ville Benavides, Rodrigo, Wyssmann, Renate Victoria Álvarez, Ortiz, Brenda Sandoval, de la Cerda, Mariana Lizbeth Rodríguez, Castañeda, Lidia Moreno, Martinez-Juarez, Luis Alberto, Gallardo-Rincón, Héctor, Tapia-Conyer, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419547/
https://www.ncbi.nlm.nih.gov/pubmed/34497714
http://dx.doi.org/10.1177/20499361211042959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419547/
https://www.ncbi.nlm.nih.gov/pubmed/34497714
http://dx.doi.org/10.1177/20499361211042959

Ejemplares similares